Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Queensland Health
Chinese Patent Office
UBS
US Army
Teva
Accenture
Federal Trade Commission
Cantor Fitzgerald

Generated: October 22, 2018

DrugPatentWatch Database Preview

Schering Plough Company Profile

« Back to Dashboard

What is the competitive landscape for SCHERING PLOUGH, and what generic and branded alternatives to SCHERING PLOUGH drugs are available?

SCHERING PLOUGH has eight approved drugs.



Summary for Schering Plough
US Patents:0
Tradenames:7
Ingredients:6
NDAs:8

Drugs and US Patents for Schering Plough

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Schering Plough IMDUR isosorbide mononitrate TABLET, EXTENDED RELEASE;ORAL 020225-003 Mar 30, 1995 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial
Schering Plough AFRINOL pseudoephedrine sulfate TABLET, EXTENDED RELEASE;ORAL 018191-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial
Schering Plough IMDUR isosorbide mononitrate TABLET, EXTENDED RELEASE;ORAL 020225-002 Aug 12, 1993 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial
Schering Plough CHLOR-TRIMETON chlorpheniramine maleate INJECTABLE;INJECTION 008826-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Schering Plough DRIXORAL PLUS acetaminophen; dexbrompheniramine maleate; pseudoephedrine sulfate TABLET, EXTENDED RELEASE;ORAL 019453-001 May 22, 1987 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Schering Plough

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Schering Plough LOTRIMIN clotrimazole CREAM;TOPICAL 017619-001 Approved Prior to Jan 1, 1982 3,660,577 ➤ Try a Free Trial
Schering Plough LOTRIMIN clotrimazole SOLUTION;TOPICAL 017613-001 Approved Prior to Jan 1, 1982 3,705,172 ➤ Try a Free Trial
Schering Plough LOTRIMIN clotrimazole CREAM;TOPICAL 017619-001 Approved Prior to Jan 1, 1982 3,839,573 ➤ Try a Free Trial
Schering Plough LOTRIMIN clotrimazole SOLUTION;TOPICAL 017613-001 Approved Prior to Jan 1, 1982 3,839,573 ➤ Try a Free Trial
Schering Plough LOTRIMIN clotrimazole CREAM;TOPICAL 017619-001 Approved Prior to Jan 1, 1982 3,705,172 ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Farmers Insurance
Queensland Health
QuintilesIMS
Chubb
Deloitte
UBS
Merck
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.